Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-25-024409
Filing Date
2025-02-11
Accepted
2025-02-11 17:16:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 POS AM d882639dposam.htm POS AM 451912
2 EX-23.1 d882639dex231.htm EX-23.1 1641
3 GRAPHIC g882639g0208024024218.jpg GRAPHIC 6557
4 GRAPHIC g882639g0208024024565.jpg GRAPHIC 3222
5 GRAPHIC g882639g0208024024718.jpg GRAPHIC 4143
  Complete submission text file 0001193125-25-024409.txt   474207
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-282162 | Film No.: 25610864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)